Why the Ramsay Health (ASX:RHC) share price is up 8% today

The Ramsay Health Care Ltd (ASX: RHC) share price is flying 8% higher today after the private hospital operator reported its half results.

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Ltd (ASX: RHC) share price is up 8% this morning after the global private healthcare company reported its half-year results.

Prior to open, Ramsay's share price was sitting at $63.28. At the time of writing, the share price stands at $68.44. The share price has been impacted over the last 12 months, falling 18.3%, with COVID-19 creating a challenging environment. It appears the market was originally preparing for weaker results.

What's moving the Ramsay Health share price?

Ramsay Health struggled through the half, with restrictions and lockdowns continuing in some of its operational regions. The impact of this was reflected in the 6.6% decline in operational revenue during the half-year. Additionally, lower demand for non-surgical services added to the dampened result.

Looking locally, Australian operations resulted in earnings before interest, tax, depreciation, and amortisation (EBITDA) of $402 million, a reduction of 21% compared to last year. Restrictions on capacity and increased costs associated with the COVID environment were held responsible for the decline.

Luckily, Ramsay experienced lifts in EBITDA across Europe and the United Kingdom. This was mostly due to cost controls and cost support payments by governments. Importantly, this levelled out EBITDA for the group to $1.039 billion, a slight reduction of 1%.

Lastly, the board has nominated to resume dividend payments to shareholders. Ramsay has declared a fully franked dividend per share of 48.5 cents, which indicates a 50% payout ratio. This decision has been made as the board holds confidence in the strong cash flows of the business.

Ramsay's light at the end of the tunnel?

Ramsay has indicated that the second half will be highly contingent on how the COVID-19 situation transpires. Vaccine rollouts have reduced the number and severity of cases based on early data. However, uncertainty remains.

The private hospital operator expects to continue investing in expanding the company's footprint. Notably, during the half, Ramsay sold 9 facilities in Germany and 2 in France.

Ramsay expects that surgeries placed on the backburner during COVID-19 disruptions will drive volumes over the next half. Some of these surgeries will also be from public waitlists, as Ramsay helps alleviate the public sector pressure.

Finally, the company provided no guidance for FY21 due to the ongoing uncertainty. It seems that shareholders are not quite out of the woods yet.

CEO commentary

CEO and managing director, Craig McNally, provided commentary on today's first-half results:

The result reflects the operational and financial resilience of the Ramsay business. Despite the disruption caused by the pandemic, we continued to invest in the business across all regions as we look to maintain our competitive advantage and optimise our portfolio of facilities

The Ramsay Health share price has unsurprisingly suffered downward pressure in the last year. Underperforming the broader market, Ramsay suffered a 15.4% fall over the 12 months gone.

Motley Fool contributor Mitchell Lawler owns shares of Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two colleagues at work looking at a tablet and smiling at a rising share price.
Share Gainers

Why Generation Development, Orica, Pro Medicus, and Zip shares are storming higher today

These shares are having a strong session on Thursday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ANZ, Brainchip, Light & Wonder, and Pilbara Minerals shares are falling today

These shares are tumbling on Thursday. But why?

Read more »

A picture of the US Federal Reserve podium for making media announcements.
Share Market News

Why the Fed just left interest rates on hold and what ASX investors can expect next

With the Fed keeping interest rates on hold, when can ASX investors expect the central bank’s next cut?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 114% in a year, why is the Pro Medicus share price leaping higher again on Thursday?

Pro Medicus shares are back in form today and leaping ahead. Here’s why.

Read more »

A railway worker walks along the train tracks in a visi vest and speaking into a walkie talkie.
Share Market News

Are Aurizon shares a buy, hold or sell based on Macquarie's report?

Here’s what this broker has to say about this Industrials stock

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Share Market News

5 things to watch on the ASX 200 on Thursday

A positive session is expected for Aussie investors today. Here's what is happening.

Read more »

Man standing on rock next to turquoise salt lagoon.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 finally had a green session this hump day.

Read more »